Table 3.
Levels of inflammatory/OS markers according to the number of MS components.
| Number of MS components | 2 (N=30) | 3 (N=60) | 4 (N=27) | p |
|---|---|---|---|---|
| IL-6 (pg/mL), median (IQR) | 1.9 (1.5) | 2.5 (1.8) | 3.0 (2.0) | 0.052 |
| TNF-α (pg/mL), median (IQR) | 0.9 (0.3)a,b | 1.1 (0.4)a,c | 1.3 (0.5)b,c | < 0.001 |
| Leptin (ng/mL), median (IQR) | 37.4 (27.4) | 39.1 (45.5) | 21.3 (26.7) | 0.272 |
| Adiponectin (μg/mL), median (IQR) | 6.0 (7.9) | 6.3 (11.7) | 3.9 (5.3) | 0.140 |
| oxLDL (U/l), median (IQR) | 71.6 (40.0) | 77.9 (27.4) | 82.3 (36.8) | 0.263 |
| oxLDL/LDL (U/mmoL), median (IQR) | 22.2 (9.7)a,b | 26.0 (10.2)a,c | 30.5 (11.2)b,c | < 0.001 |
| oxLDL/HDL (U/mmoL), median (IQR) | 53.2 (42.0)a | 58.5 (28.0) | 83.1 (42.5)a | 0.016 |
| MPO (ng/mL), median (IQR) | 96.1 (162.5) | 76.6 (112.8) | 72.2 (151.6) | 0.872 |
| CRP (mg/L), median (IQR) | 2.8 (4.2) | 2.4 (3.9) | 1.6 (4.3) | 0.596 |
Data are expressed as median (interquartile range, IQR). MS, metabolic syndrome; IL-6, interleukin-6; TNF-α, tumor necrosis factor-α; oxLDL, oxidized low density lipoprotein; HDL, high-density lipoprotein; LDL, low-density lipoprotein; MPO, myeloperoxidase; CRP, C-reactive protein. Comparisons between groups were performed by the Kruskal-Wallis test. Level of significance was set as 0.05. Significant p are in bold. Different superscript levels (a, b, c) represent significant differences between groups.